RISK FACTORS FOR THE DEVELOPMENT OF FATTY LIVER IN ELDERLY PEOPLE LIVING IN THE FERGANA VALLEY OF THE REPUBLIC OF UZBEKISTAN

Article Sidebar

pdf
Published: May 23, 2024
Keywords:
progressive fibrosis; aged people; metabolic syndrome; non-alcoholic fatty liver disease.

Main Article Content

Usmonov E. I.
Vasilevski E. A.

Abstract

Globally, the proportion of older people aged 65 years and over continues to increase (5). According to UN statistics, in 2019, the elderly population aged 65 years and over accounted for 9% of the total population, and this proportion is projected to increase to 16% by 2050 and exceed 23% by 2100 (3,6). Age is a major risk factor for the development of chronic diseases, and more than 50% of older adults suffer from at least one type of chronic disease (2,4). These chronic diseases pose a significant healthcare burden that will become even worse in the future (1,7). Therefore, it is advisable to prevent the occurrence of these diseases as early as possible.

Article Details

How to Cite
Usmonov E. I., & Vasilevski E. A. (2024). RISK FACTORS FOR THE DEVELOPMENT OF FATTY LIVER IN ELDERLY PEOPLE LIVING IN THE FERGANA VALLEY OF THE REPUBLIC OF UZBEKISTAN. Proceedings of International Educators Conference, 3(5), 279–281. Retrieved from https://econferenceseries.com/index.php/iec/article/view/4803
Issue
Vol. 3 No. 5 (2024): IEC
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

References

Drapkina O.M. Non-alcoholic fatty liver disease and cardiovascular risk: state of the problem. Rational Pharmacotherapy in Cardiology. – 2017. – T. 13, No. 5. – P. 645-650.

Song R., Hu M., Qin X., Qiu L., Wang P., Zhang X., Liu R., Wang X. The Roles of Lipid Metabolism in the Pathogenesis of Chronic Diseases in the Elderly. - Nutrients. - 2023 - No. 15(Vol/15) - P. 3433

United Nations, Department of Economic and Social Affairs, Population Division World Population Prospects 2019: Highlights. 2019. [(accessed on 15 June 2022)]. ST/ESA/SER.A/423.

Katsiki N., Kolovou G., Perez-Martinez P., Mikhailidis D.P. Dyslipidaemia in the Elderly: To Treat or Not to Treat? - Expert Rev. Clin. Pharmacol. - 2018 - No. 11 - R. 259–278.

Zemedikun D.T., Gray L.J., Khunti K., Davies M.J., Dhalwani N.N. Patterns of Multimorbidity in Middle-Aged and Older Adults: An Analysis of the UK Biobank Data. - Mayo Clin. Proc. - 2018 - No. 93 - R. 857–866.

Yan Y., Wu T., Zhang M., Li C., Liu Q., Li F. Prevalence, Awareness and Control of Type 2 Diabetes Mellitus and Risk Factors in Chinese Elderly Population. - BMC Public Health -2022 - No. 22 - R. 1382.

Ames B.N. Prolonging Healthy Aging: Longevity Vitamins and Proteins.- Proc. Natl. Acad. Sci. USA. - 2018- No. 115 - R.10836–10844.